|
Analyte |
Abnormal result |
Cause |
|
Glucose |
<3.4 mmol/L (60 mg/dL) |
Malignant or parapneumonic effusion, pleural empyema, tuberculosis |
|
<1.6 mmol/L (29 mg/dL) |
Pleural empyema, rheumatoid arthritis |
|
|
pH |
<7.2 |
Parapneumonic effusion with complications, pleural empyema, esophageal perforation |
|
Triglycerides |
>1.24 mmol/L (110 mg/dL) |
Chylothorax (if chylomicrons and no cholesterol crystals are observed) |
|
Cholesterol |
>5.18 mmol/L (200 mg/dL) and crystals |
Pseudochylothorax |
|
Amylase |
Increased activity |
Acute pancreatitis, esophageal rupture, pleural malignancies (particularly adenocarcinoma) |
|
ADA |
≥40 IU/L |
Tuberculous pleuritis (identification of the ADA-2 isoform increases test specificity) |
|
Hematocrit |
≥50% of peripheral blood hematocrit |
Hemothorax |
|
Neutrophils |
Present |
Bacterial infection, pulmonary embolism |
|
Lymphocytes |
Present |
Tuberculosis, malignancies |
|
Eosinophils |
>10% |
Asbestosis, malignancy, parasitic infestation, granulomatosis with polyangiitis, drug-induced reaction, hemothorax or pneumothorax |
|
Light criteria for differentiation between transudates and exudates: proteinfluid/proteinserum >0.5, LDHfluid/LDHserum >0.6, LDHfluid/LDHserum ULN >2/3; each of these criteria indicates an exudate. |
||
|
ADA, adenosine deaminase; LDH, lactate dehydrogenase; ULN, upper limit of normal. |
||